Géraldine Laumond

698 total citations
37 papers, 455 citations indexed

About

Géraldine Laumond is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Géraldine Laumond has authored 37 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Virology, 24 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Géraldine Laumond's work include HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (18 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Géraldine Laumond is often cited by papers focused on HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (18 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Géraldine Laumond collaborates with scholars based in France, Spain and United States. Géraldine Laumond's co-authors include Christiane Moog, Sylvie Schmidt, Thomas Decoville, Anné-Marie Aubertin, Bin Su, Jean‐Bernard Regnouf‐de‐Vains, Marina E. Biedma, Maxime Mourer, Maryse Peressin and Jean‐Christophe Paillart and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Géraldine Laumond

35 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Laumond France 14 244 156 155 152 84 37 455
Marie K. Mankowski United States 15 402 1.6× 345 2.2× 176 1.1× 88 0.6× 59 0.7× 23 604
Renee Hrin United States 11 418 1.7× 245 1.6× 330 2.1× 168 1.1× 90 1.1× 15 685
Roy W. Johnson United States 6 126 0.5× 123 0.8× 246 1.6× 154 1.0× 48 0.6× 8 516
Beatriz Apellániz Spain 15 245 1.0× 89 0.6× 408 2.6× 108 0.7× 28 0.3× 28 582
Anastasia Selyutina United States 11 246 1.0× 160 1.0× 187 1.2× 86 0.6× 60 0.7× 18 427
D. Cameron Dunlop United Kingdom 8 454 1.9× 111 0.7× 296 1.9× 319 2.1× 67 0.8× 8 679
S. Bryson Canada 12 157 0.6× 57 0.4× 271 1.7× 110 0.7× 44 0.5× 15 482
Neelakshi Gohain United States 13 194 0.8× 68 0.4× 212 1.4× 203 1.3× 43 0.5× 23 466
Lawrence J. Tartaglia United States 9 139 0.6× 74 0.5× 149 1.0× 73 0.5× 45 0.5× 13 307

Countries citing papers authored by Géraldine Laumond

Since Specialization
Citations

This map shows the geographic impact of Géraldine Laumond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Laumond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Laumond more than expected).

Fields of papers citing papers by Géraldine Laumond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Laumond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Laumond. The network helps show where Géraldine Laumond may publish in the future.

Co-authorship network of co-authors of Géraldine Laumond

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Laumond. A scholar is included among the top collaborators of Géraldine Laumond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Laumond. Géraldine Laumond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Li‐Yun, Mkunde Chachage, Géraldine Laumond, et al.. (2025). Deciphering HIV vaccine-induced antibody response according to ethnicity. AIDS. 39(8). 957–963.
2.
Laumond, Géraldine, et al.. (2022). Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins. International Journal of Molecular Sciences. 23(24). 15511–15511. 2 indexed citations
3.
Moog, Christiane, et al.. (2020). Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors. Journal of Molecular Biology. 432(20). 5577–5592. 10 indexed citations
4.
Morel, Bertrand, Christiane Moog, Sylvie Schmidt, et al.. (2019). Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins. Journal of Molecular Biology. 431(17). 3091–3106. 16 indexed citations
5.
Su, Bin, Luzia Mayr, Jéromine Klingler, et al.. (2018). HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies. AIDS. 32(10). 1239–1245. 1 indexed citations
6.
Guerrero, Santiago, Julien Batisse, Gaëlle Mercenne, et al.. (2016). Translational regulation of APOBEC3G mRNA by Vif requires its 5′UTR and contributes to restoring HIV-1 infectivity. Scientific Reports. 6(1). 39507–39507. 17 indexed citations
7.
Boutant, Emmanuel, Marina E. Biedma, Kamal Kant Sharma, et al.. (2016). Characterization of the interaction between the HIV-1 Gag structural polyprotein and the cellular ribosomal protein L7 and its implication in viral nucleic acid remodeling. Retrovirology. 13(1). 54–54. 23 indexed citations
8.
Su, Bin, Maryse Peressin, Luzia Mayr, et al.. (2015). Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection. AIDS Research and Human Retroviruses. 31(11). 1187–1191. 6 indexed citations
9.
Su, Bin, et al.. (2014). Antibody Inhibition of HIV-1 Transmission from Antigen-presenting Cells to CD4 T Lymphocytes Involves Immune Cell Activation. AIDS Research and Human Retroviruses. 30(S1). A154–A154. 1 indexed citations
10.
Su, Bin, Vincent Holl, Sylvie Schmidt, et al.. (2014). Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production. Scientific Reports. 4(1). 5845–5845. 10 indexed citations
11.
Peressin, Maryse, Alizé Proust, Sylvie Schmidt, et al.. (2014). Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes. AIDS. 28(5). 667–677. 25 indexed citations
12.
Su, Bin, Ke Xu, Maryse Peressin, et al.. (2012). Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes. Blood. 120(18). 3708–3717. 28 indexed citations
13.
Holl, Vincent, Ke Xu, Maryse Peressin, et al.. (2010). Stimulation of HIV-1 Replication in Immature Dendritic Cells in Contact with Primary CD4 T or B Lymphocytes. Journal of Virology. 84(9). 4172–4182. 14 indexed citations
14.
Paillart, Jean‐Christophe, Géraldine Laumond, Anné-Marie Aubertin, et al.. (2010). 5-Modified-2′-dU and 2′-dC as Mutagenic Anti HIV-1 Proliferation Agents: Synthesis and Activity. Journal of Medicinal Chemistry. 53(4). 1534–1545. 18 indexed citations
15.
Mourer, Maxime, et al.. (2009). Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands. Bioorganic & Medicinal Chemistry. 18(1). 36–45. 55 indexed citations
16.
Fossey, Christine, et al.. (2007). Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(5). 591–607. 5 indexed citations
17.
Fossey, Christine, Ngoc Trinh Huynh, Irina Zarafu, et al.. (2007). Synthesis and anti-HIV evaluation of hybrid-type prodrugs conjugating HIV integrase inhibitors with d4t by self-cleavable spacers containing an amino acid residue. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(5). 608–619. 4 indexed citations
18.
Fossey, Christine, et al.. (2004). Synthesis and Anti-HIV Activity of Some [Nucleoside Reverse Transcriptase Inhibitor]-C5′-Linker-[Integrase Inhibitor] Heterodimers as Inhibitors of HIV Replication. Journal of Enzyme Inhibition and Medicinal Chemistry. 19(6). 497–509. 4 indexed citations
19.
Fossey, Christine, et al.. (2003). Synthesis of Certain Heterodimers Expected as HIV-1 Reverse Transcriptase Inhibitors. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 873–875. 6 indexed citations
20.
Fossey, Christine, et al.. (2002). SYNTHESIS AND ANTI-HIV ACTIVITY OF [D4U]-[TROVIRDINE ANALOGUE] AND [D4T]-[TROVIRDINE ANALOGUE] HETERODIMERS AS INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE. Nucleosides Nucleotides & Nucleic Acids. 21(8-9). 505–533. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie K. Mankowski Breakdown of academic impact, for papers by Renee Hrin Breakdown of academic impact, for papers by Roy W. Johnson Breakdown of academic impact, for papers by Beatriz Apellániz Breakdown of academic impact, for papers by Anastasia Selyutina Breakdown of academic impact, for papers by D. Cameron Dunlop Breakdown of academic impact, for papers by S. Bryson Breakdown of academic impact, for papers by Neelakshi Gohain Breakdown of academic impact, for papers by Lawrence J. Tartaglia
Rankless by CCL
2026